Evidence map›Paper›PMID 42791352›Full record

ArticleEMBO reports2026

BBX maintains mammalian brain development by repressing p53-mediated p21 expression.

Youngik Yoon, Gwang Yeong Kim, Woo Young Lim, Saeah Hwang, Solji Lee, Dongrok Yoon, Samuel J Pleasure, Keejung Yoon

Abstract read
PubMed Publisher
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Youngik YoonDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, South Korea.ORCID http://orcid.org/0000-0002-6024-9348
Gwang Yeong KimDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, South Korea.
Woo Young LimDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, South Korea.
Saeah HwangDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, South Korea.
Solji LeeDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, South Korea.
Dongrok YoonDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, South Korea.
Samuel J PleasureDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-8599-1613
Keejung YoonDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, South Korea. keejung@skku.edu.ORCID http://orcid.org/0000-0002-2361-9039

Funding

National Research Foundation of Korea (NRF) 2021R1A2C1009018National Research Foundation of Korea (NRF) RS-2026-25600798
6 · The paper itself

Abstract

Brain development requires coordinated regulation of neural stem cell (NSC) proliferation, differentiation, and neuronal migration. Here, we identify bobby sox homolog (BBX), a nuclear HMG box domain-containing protein enriched in mouse embryonic cortical germinal zones, as a regulator of corticogenesis. In the embryonic cortex, BBX depletion reduces SOX2-expressing NSCs, promotes premature cell-cycle exit, disrupts cortical cell positioning, causes abnormal clustering of newborn neurons, and impairs migratory neuron morphology. RNA-seq and public ChIP-seq analyses, together with biochemical assays, show that BBX interacts with p53 and suppresses p53-dependent p21 expression. Consistent with activation of the p21 pathway, BBX knockdown increases premature cell-cycle exit and senescence-associated features, including γH2AX accumulation and senescence-associated gene expression. Co-depletion of p21 rescues BBX knockdown-induced defects in NSC maintenance, neuronal distribution, and morphology. In line with this, depletion of retinoblastoma protein (RB), a major mediator of p21-dependent senescence, restores abnormal cortical cell distribution. These findings indicate that BBX maintains normal cortical development by restraining the p53-p21-RB axis, thereby preventing premature cell-cycle exit and senescence in developing neural cells.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.